On this page
Alogliptin
ALOGLIPTIN BENZOATE
Active ingredient 5 prescription 12 with labelling
Overview
Source: NDC DirectoryIngredient name
ALOGLIPTIN BENZOATE
Base moiety
ALOGLIPTIN
RxNorm CUI
UNII
EEN99869SC
Medication products
10
Brand names
6
Dosage forms
2
FAERS reports
91,381 · not a risk measure
- Alogliptin Powder
- Alogliptin Benzoate Powder
- Alogliptin Benzoate and Pioglitazone Hydrochloride Tablet, Film Coated
- alogliptin/pioglitazone Tablet, Film Coated
- Alogliptin Tablet, Film Coated
- alogliptin and metformin hydrochloride Tablet, Film Coated
- Alogliptin and Pioglitazone Alogliptin Benzoate and Pioglitazone hydrochloride · Tablet, Film Coated
- KAZANO alogliptin and metformin hydrochloride · Tablet, Film Coated
- Nesina alogliptin · Tablet, Film Coated
- OSENI alogliptin and pioglitazone · Tablet, Film Coated
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| TABLET, Film Coated | 8 | Alogliptin Benzoate and Pioglitazone Hydrochloride, alogliptin/pioglitazone, Alogliptin, alogliptin and metformin hydrochloride … |
| Powder | 2 | Alogliptin, Alogliptin Benzoate |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |